ADAMO, ANNALISA
 Distribuzione geografica
Continente #
EU - Europa 781
NA - Nord America 640
AS - Asia 329
SA - Sud America 4
OC - Oceania 2
AF - Africa 1
Totale 1.757
Nazione #
US - Stati Uniti d'America 634
CN - Cina 244
IT - Italia 212
GB - Regno Unito 200
IE - Irlanda 82
DE - Germania 76
SE - Svezia 71
FR - Francia 49
FI - Finlandia 34
VN - Vietnam 30
RU - Federazione Russa 20
HK - Hong Kong 14
KR - Corea 13
TW - Taiwan 9
AT - Austria 8
BE - Belgio 7
ES - Italia 6
ID - Indonesia 6
CA - Canada 5
TR - Turchia 5
UA - Ucraina 5
CH - Svizzera 3
CL - Cile 3
NL - Olanda 3
AU - Australia 2
IR - Iran 2
JP - Giappone 2
RO - Romania 2
SG - Singapore 2
CO - Colombia 1
CZ - Repubblica Ceca 1
IN - India 1
MY - Malesia 1
PA - Panama 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 1.757
Città #
Southend 185
Chandler 164
Dublin 82
Verona 71
Beijing 68
Ashburn 54
New York 50
Ann Arbor 28
Houston 27
Woodbridge 27
Jinan 26
Helsinki 19
Lawrence 19
Princeton 19
Shenyang 19
Nanjing 17
Dong Ket 16
Tianjin 16
Jacksonville 15
Redmond 12
Dearborn 11
Icheon-si 11
Wilmington 11
Cagliari 8
Changsha 8
Hangzhou 8
Seattle 8
Sindelfingen 8
Vienna 8
Zhengzhou 8
Bologna 7
Lancaster 7
Nanchang 7
Ningbo 7
Haikou 6
Jiaxing 6
Milan 6
Redwood City 6
San Giovanni Lupatoto 6
Sant'Ambrogio di Valpolicella 6
Chions 5
Ha Kwai Chung 5
Hebei 5
Isola della Scala 5
New Taipei 5
Oakland 5
Brussels 4
Central 4
Guangzhou 4
Istanbul 4
Padova 4
Pingzhen District 4
Pontevedra 4
Rawa Buaya 4
Vancouver 4
Washington 4
Cerea 3
Fairfield 3
Herstal 3
Ome 3
Putian 3
San Francisco 3
Taiyuan 3
Taizhou 3
Trento 3
Trieste 3
Berlin 2
Cambridge 2
Chicago 2
Davis 2
Denver 2
Düsseldorf 2
Frankfurt am Main 2
Fuzhou 2
Gambir 2
Genova 2
Greifswald 2
Isola Rizza 2
Kuopio 2
Lana 2
Lappeenranta 2
Leipzig 2
Luton 2
Mehlingen 2
Melbourne 2
Norwalk 2
Novara 2
Santiago 2
Silea 2
Singapore 2
Sprang 2
Timisoara 2
Tokyo 2
Vicenza 2
Villasanta 2
Wanchai 2
Ahvaz 1
Arco 1
Asti 1
Birmingham 1
Totale 1.251
Nome #
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 144
Extracellular vesicles mediate mesenchymal stromal cell-dependent regulation of B cell functions 134
Notch singalling inhibition as a multi-target therapy to overcome bone marrow microenvironment-mediated drug resistance in AML 120
Molecular characterization of msc-derived extracellular vesicles and correlation with their immunomodulatory potential 120
Role of GSK-3 signalling in non-promyelocitic acute myeloid leukemia (AML) cell response to chemotherapy 115
Inhibition of GSK-3 Signalling Enhances Sensitivity of Non-Promyelocitic Acute Myeloid Leukemia (AML) Cell to Chemotherapy 105
Differential and transferable modulatory effects of mesenchymal stromal cell-derived extracellular vesicles on T, B and NK cell functions 103
Role of Wnt/β-Catenin Signalling in Acute Myeloid Leukemia (AML) Cell Response to Chemotherapy 99
Rational of targeting WNT/beta-catenin signaling in acute myeloid leukemia (AML) 95
CHARACTERIZATION OF MESENCHYMAL STROMAL CELL-DERIVED EXTRACELLULAR VESICLES AND CORRELATION WITH THEIR IMMUNOSUPPRESSIVE PROPERTIES TOWARDS B CELLS 88
Extracellular Vesicles Mediate Mesenchymal Stromal Cell-Dependent Regulation of B Cell PI3K-AKT Signaling Pathway and Actin Cytoskeleton 84
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 80
Inhibition of Notch signaling enhances chemosensitivity in B cell precursor acute lymphoblastic leukemia 70
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis 66
Discovery of highly potent benzimidazole derivatives as indoleamine 2,3-dioxygenase-1 (IDO1) inhibitors: from structure-based virtual screening to in vivo pharmacodynamic activity 62
Functional dosing of mesenchymal stromal cell-derived extracellular vesicles for the prevention of acute graft-versus-host-disease 51
Small Molecule Inhibitors of Microenvironmental Wnt/β-Catenin Signaling Enhance the Chemosensitivity of Acute Myeloid Leukemia 48
HS-5 and HS-27A Stromal Cell Lines to Study Bone Marrow Mesenchymal Stromal Cell-Mediated Support to Cancer Development 42
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 41
High-throughput analysis and functional interpretation of extracellular vesicle content in hematological malignancies 39
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients 24
Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy 23
Circulating IgG4+ Plasmablast Count as a Diagnostic Tool in Autoimmune Pancreatitis 19
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 16
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 9
Moonlighting Proteins Are Important Players in Cancer Immunology 6
Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade. 5
Common PHOX2B poly-alanine contractions impair RET gene transcription, predisposing to Hirschsprung disease. 4
Beneficial Effect of Phenytoin and Carbamazepine on GFAP Gene Expression and Mutant GFAP Folding in a Cellular Model of Alexander's Disease 3
Structural and functional differences in PHOX2B frameshift mutations underlie isolated or syndromic congenital central hypoventilation syndrome. 3
Totale 1.818
Categoria #
all - tutte 5.721
article - articoli 3.684
book - libri 0
conference - conferenze 1.513
curatela - curatele 0
other - altro 524
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.442


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201920 0 0 0 0 0 0 0 0 0 6 7 7
2019/2020184 15 0 5 17 11 34 9 11 16 27 12 27
2020/2021205 31 24 13 30 18 25 8 0 4 2 14 36
2021/2022198 13 69 11 5 15 1 5 15 10 3 7 44
2022/2023490 21 61 35 80 31 129 0 37 68 2 18 8
2023/2024392 10 20 31 64 79 92 26 52 8 10 0 0
Totale 1.818